Physiologically based pharmacokinetic models: integration of in silico approaches with micro cell culture analogues.


There is a large emphasis within the pharmaceutical industry to provide tools that will allow early research and development groups to better predict dose ranges for and metabolic responses of candidate molecules in a high throughput manner, prior to entering clinical trials. These tools incorporate approaches ranging from PBPK, QSAR, and molecular dynamics… (More)


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.